PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Quality of Life in Patients With Advanced Renal Cell Carcinoma: Are We Measuring What Matters?
Visit https://www.peervoice.com/HWT860 to view the entire programme with slides. After completing “Quality of Life in Patients With Advanced Renal Cell Carcinoma: Are We Measuring What Matters?”, participants will be able to: Describe the impact of advanced renal cell carcinoma (aRCC) on patients’ quality of life (QoL) and its assessment with evidence-based tools; Summarise the latest QoL data for therapeutic strategies for untreated aRCC; Appraise how the QoL data alongside the efficacy/safety data may inform the individualised management of patients with aRCC now and into the future